Welfare benefit utilization for people with functional somatic disorder. A population-based cohort study

IF 3.5 2区医学 Q2 PSYCHIATRY

Journal of Psychosomatic Research Pub Date : 2025-02-27 DOI:10.1016/j.jpsychores.2025.112073

Marie Weinreich Petersen , Kaare Bro Wellnitz , Tina Birgitte Wisbech Carstensen , Thomas Meinertz Dantoft , Eva Ørnbøl , Anne Ahrendt Bjerregaard , Torben Jørgensen , Per Fink

{"title":"Welfare benefit utilization for people with functional somatic disorder. A population-based cohort study","authors":"Marie Weinreich Petersen , Kaare Bro Wellnitz , Tina Birgitte Wisbech Carstensen , Thomas Meinertz Dantoft , Eva Ørnbøl , Anne Ahrendt Bjerregaard , Torben Jørgensen , Per Fink","doi":"10.1016/j.jpsychores.2025.112073","DOIUrl":null,"url":null,"abstract":"<div><div>Clinical studies indicate that functional somatic disorder (FSD), a condition characterized by persistent physical symptoms not attributable to other physical or mental conditions, imposes a high socioeconomic burden, but high-quality studies on its impact on welfare benefit utilization in the general population are lacking. This study investigated the use of sickness benefit, unemployment benefit, and disability pension for individuals with FSD using nationwide Danish registers.</div><div>This study included 9656 adults from the DanFunD study. FSD were identified via self-reported questionnaires and diagnostic interviews. Data on welfare benefits were sourced from The Danish Register for Evaluation of Marginalization, counting the mean number of weeks per year over 10 years before and 4 years after the DanFunD study. Analyses used sex- and age-adjusted regression with non-parametric bootstrap resampling (10,000 repetitions).</div><div>Compared to those without FSD, individuals with FSD received an annual average of 3.9 (95 % CI: 3.3–4.4) more weeks of sickness benefit, 1.3 (95 % CI: 1.0–1.6) more weeks of unemployment benefit, and 3.8 (95 % CI: 3.2–4.5) more weeks of disability pension in the 10 years before DanFunD. This pattern persisted in the 4 years after DanFunD and for those diagnosed by interviews. Individuals with questionnaire-defined FSD had higher welfare benefit use than individuals with other severe physical diseases.</div><div>Individuals with FSD use welfare benefits significantly more than those without FSD and those with other severe physical diseases. This study highlights FSD as a disabling condition with a substantial individual and societal impact, emphasizing the need for timely diagnosis and treatment.</div><div><strong>Trial registration:</strong> <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span> Identifier: <span><span>NCT05611606</span><svg><path></path></svg></span></div></div>","PeriodicalId":50074,"journal":{"name":"Journal of Psychosomatic Research","volume":"191 ","pages":"Article 112073"},"PeriodicalIF":3.5000,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Psychosomatic Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022399925000376","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

Clinical studies indicate that functional somatic disorder (FSD), a condition characterized by persistent physical symptoms not attributable to other physical or mental conditions, imposes a high socioeconomic burden, but high-quality studies on its impact on welfare benefit utilization in the general population are lacking. This study investigated the use of sickness benefit, unemployment benefit, and disability pension for individuals with FSD using nationwide Danish registers.

This study included 9656 adults from the DanFunD study. FSD were identified via self-reported questionnaires and diagnostic interviews. Data on welfare benefits were sourced from The Danish Register for Evaluation of Marginalization, counting the mean number of weeks per year over 10 years before and 4 years after the DanFunD study. Analyses used sex- and age-adjusted regression with non-parametric bootstrap resampling (10,000 repetitions).

Compared to those without FSD, individuals with FSD received an annual average of 3.9 (95 % CI: 3.3–4.4) more weeks of sickness benefit, 1.3 (95 % CI: 1.0–1.6) more weeks of unemployment benefit, and 3.8 (95 % CI: 3.2–4.5) more weeks of disability pension in the 10 years before DanFunD. This pattern persisted in the 4 years after DanFunD and for those diagnosed by interviews. Individuals with questionnaire-defined FSD had higher welfare benefit use than individuals with other severe physical diseases.

Individuals with FSD use welfare benefits significantly more than those without FSD and those with other severe physical diseases. This study highlights FSD as a disabling condition with a substantial individual and societal impact, emphasizing the need for timely diagnosis and treatment.

Trial registration: ClinicalTrials.gov Identifier: NCT05611606

查看原文本刊更多论文

功能性躯体障碍患者的福利待遇利用。一项基于人群的队列研究

临床研究表明，功能性躯体障碍（FSD）是一种以不能归因于其他身体或精神状况的持续躯体症状为特征的疾病，它给社会经济带来了沉重的负担，但缺乏关于其对普通人群福利福利利用影响的高质量研究。本研究使用丹麦全国范围内的登记资料调查了FSD患者的疾病福利、失业福利和残疾养老金的使用情况。这项研究包括来自DanFunD研究的9656名成年人。消防处是通过自我报告的问卷和诊断性访谈来确定的。关于福利的数据来自丹麦边缘化评估登记册，计算了DanFunD研究之前10年和之后4年每年的平均周数。分析使用性别和年龄调整回归与非参数自助重采样（10,000次重复）。与没有FSD的人相比，有FSD的人在DanFunD之前的10年里平均每年多获得3.9周（95% CI: 3.3-4.4）的疾病津贴，1.3周（95% CI: 1.0-1.6）的失业津贴，3.8周（95% CI: 3.2-4.5）的残疾津贴。这种模式在DanFunD之后的4年里以及通过访谈确诊的患者中持续存在。患有问卷定义的FSD的个体比患有其他严重身体疾病的个体有更高的福利福利使用。患有FSD的个体比没有FSD的个体和患有其他严重身体疾病的个体使用更多的福利。这项研究强调了FSD是一种对个人和社会都有重大影响的致残疾病，强调了及时诊断和治疗的必要性。试验注册：ClinicalTrials.gov标识符：NCT05611606

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Psychosomatic Research 医学-精神病学

CiteScore

7.40

自引率

6.40%

发文量

314

审稿时长

6.2 weeks

期刊介绍： The Journal of Psychosomatic Research is a multidisciplinary research journal covering all aspects of the relationships between psychology and medicine. The scope is broad and ranges from basic human biological and psychological research to evaluations of treatment and services. Papers will normally be concerned with illness or patients rather than studies of healthy populations. Studies concerning special populations, such as the elderly and children and adolescents, are welcome. In addition to peer-reviewed original papers, the journal publishes editorials, reviews, and other papers related to the journal''s aims.